Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study

Peer Review reports

Original Submission
5 Feb 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
15 Apr 2013	Reviewed	Reviewer Report - Jennifer Chan
3 May 2013	Reviewed	Reviewer Report - Antonio Bianchi
9 Jul 2013	Author responded	Author comments - Eva Pineda
Resubmission - Version 3
9 Jul 2013	Submitted	Manuscript version 3
20 Aug 2013	Reviewed	Reviewer Report - Jennifer Chan
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
11 Sep 2013	Editorially accepted
20 Sep 2013	Article published	10.1186/1471-2407-13-427

Back to article page